Primary role of angiotensin-converting enzyme-2 in cardiac production of anglotensin-(1-7) in transgenic Ren-2 hypertensive rats

被引:43
|
作者
Trask, Aaron J. [1 ]
Averill, David B.
Ganten, Detlev
Chappell, Mark C.
Ferrario, Carlos M.
机构
[1] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA
[2] Univ Med Berlin, Charite, Berlin, Germany
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2007年 / 292卷 / 06期
关键词
angiotensin II; hypertension; isolated heart;
D O I
10.1152/ajpheart.01198.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary role of angiotensin-converting enzyme 2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. Am J Physiol Heart Circ Physiol 292: H3019-H3024. 2007. First published February 16, 2007: doi: 10.1152/ajplicart.01198.2006. - Angiotensin-converting enzyme-2 (ACE2) converts angiotensin 11 (ANG 11) to angiotensin-(1-7) [ANG-(1-7)], and this enzyme may serve as a key regulatory juncture in various tissues. Although the heart expresses ACE2, the extent that the enzyme participates in the cardiac processing of ANG 11 and ANG-(1-7) is equivocal. Therefore. we utilized the Langendorff preparation to characterize the ACE2 pathway in isolated hearts from male normotensive Sprague-Dawley [Tg((-))] and hypertensive [mRen2]27 [TL(+)] rats. During a 60-min recirculation period with 10 nM ANG II. he presence of ANG-(1-7) was assessed in the cardiac effluent. ANG-(1-7) generation from ANG 11 was similar in both the normal and hypertensive hearts [Tg(-) : 510 +/- 55 pM, n = 20 vs. Tg((+)): 497 +/- 63 pM, n = 14] with peak levels occurring at 30 min after administration of the peptide. ACE2 inhibition (MLN-4760, I LM) sianificantly reduced ANG-(1-7) production by 83% (57 +/- 19 pM,. P < 0.01. n = 7) in the Tg((+)) rats. whereas the inhibitor had no significant effect in the TL, -) rats (285 +/- 53 pM, P > 0.05, n = 10). ACE2 activity was found in the effluent of perfused Tg((-)) and Tg((+)) hearts. and it was highly associated with ACE2 protein expression (r = 0.78). This study is the first demonstration for a direct role of ACE2 in the metabolism of cardiac ANG 11 in the hypertrophic heart of hypertensive rats. We Conclude that predominant expression of cardiac ACE2 activity in the Tg((+)) may be a compensatory response to the extensive cardiac remodeling in this strain.
引用
收藏
页码:H3019 / H3024
页数:6
相关论文
共 50 条
  • [21] Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review
    Ferreira, Anderson J.
    Bader, Michael
    Santos, Robson A. S.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (05) : 567 - 574
  • [22] FUNCTIONAL VASCULAR RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE TRANSGENIC RATS FOR THE MOUSE RENIN GENE REN-2
    ARRIBAS, S
    SANCHEZFERRER, CF
    PEIRO, C
    PONTE, A
    SALAICES, M
    MARIN, J
    GENERAL PHARMACOLOGY, 1994, 25 (06): : 1163 - 1170
  • [23] Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy
    Ni, Jun
    Yang, Fuye
    Huang, Xiao-Ru
    Meng, Jinxiu
    Chen, Jiaoyi
    Bader, Michael
    Penninger, Josef M.
    Fung, Erik
    Yu, Xue-Qing
    Lan, Hui-Yao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (22) : 13093 - 13103
  • [24] Sex Differences in Angiotensin-Converting Enzyme Modulation of Ang (1-7) Levels in Normotensive WKY Rats
    Bhatia, Kanchan
    Zimmerman, Margaret A.
    Sullivan, Jennifer C.
    AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (05) : 591 - 598
  • [25] Association between circulating angiotensin-converting enzyme 2 and cardiac remodeling in hypertensive patients
    Li, Shichao
    Wang, Zhijun
    Yang, Xiuhong
    Hu, Bo
    Huang, Yuling
    Fan, Sujing
    PEPTIDES, 2017, 90 : 63 - 68
  • [26] Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis
    Herath, Chandana B.
    Warner, Fiona J.
    Lubel, John S.
    Dean, Rachael G.
    Jia, Zhiyuan
    Lew, Rebecca A.
    Smith, A. Ian
    Burrell, Louise M.
    Angus, Peter W.
    JOURNAL OF HEPATOLOGY, 2007, 47 (03) : 387 - 395
  • [27] Effect of Angiotensin-Converting Enzyme Blockade, Alone or Combined With Blockade of Soluble Epoxide Hydrolase, on the Course of Congestive Heart Failure and Occurrence of Renal Dysfunction in Ren-2 Transgenic Hypertensive Rats With Aorto-Caval Fistula
    Kala, P.
    Sedlakova, L.
    Skaroupkova, P.
    Kopkan, L.
    Vanourkova, Z.
    Taborsky, M.
    Nishiyama, A.
    Hwang, S. H.
    Hammock, B. D.
    Sadowski, J.
    Melenovsky, V
    Imig, J. D.
    Cervenka, L.
    PHYSIOLOGICAL RESEARCH, 2018, 67 (03) : 401 - 415
  • [28] The Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas receptor axis: A potential target for treating thrombotic diseases
    Fraga-Silva, Rodrigo A.
    Da Silva, Danielle G.
    Montecucco, Fabrizio
    Mach, Francois
    Stergiopulos, Nikolaos
    da Silva, Rafaela F.
    Santos, Robson A. S.
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (06) : 1089 - 1096
  • [29] Plasma and kidney angiotensin II levels and renal functional responses to AT1 receptor blockade in hypertensive Ren-2 transgenic rats
    Kopkan, L
    Kramer, HJ
    Husková, Z
    Vanourková, Z
    Bäcker, A
    Bader, M
    Ganten, D
    Cervenka, L
    JOURNAL OF HYPERTENSION, 2004, 22 (04) : 819 - 825
  • [30] Exaggerated blood pressure response to fasudil or nifedipine in hypertensive Ren-2 transgenic rats: role of altered baroreflex
    Vaneckova, Ivana
    Behuliak, Michal
    Hojna, Silvie
    Kopkan, Libor
    Kadlecova, Michaela
    Zicha, Josef
    HYPERTENSION RESEARCH, 2019, 42 (02) : 145 - 154